XJPX
7061
Market cap78mUSD
Apr 04, Last price
1,376.00JPY
1D
-6.20%
1Q
-1.01%
IPO
-36.47%
Name
Japan Hospice Holdings Inc
Chart & Performance
P/E
18.15
P/S
0.96
EPS
75.82
Div Yield, %
—
Shrs. gr., 5y
1.64%
Rev. gr., 5y
23.64%
Revenues
12.12b
+22.72%
Net income
639m
-6.29%
CFO
835m
-26.14%
Profile
Japan Hospice Holdings Inc. engages in hospice housing and home care businesses in Japan. The company offers care services at hospice housing for patients with terminal cancer and intractable diseases; and home-visit nursing services. It also provides home care services, which supports medical care, including physical care and life support, as well as offers day and nursing multi-function home care services. The company was founded in 2017 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | ||||||||
Revenues | 12,115,000 22.72% | 9,871,866 25.05% | 7,894,317 31.15% | |||||
Cost of revenue | 10,428,000 | 8,293,000 | 6,696,475 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 1,687,000 | 1,578,866 | 1,197,842 | |||||
NOPBT Margin | 13.92% | 15.99% | 15.17% | |||||
Operating Taxes | 368,000 | 346,453 | 305,581 | |||||
Tax Rate | 21.81% | 21.94% | 25.51% | |||||
NOPAT | 1,319,000 | 1,232,413 | 892,261 | |||||
Net income | 639,000 -6.29% | 681,880 49.95% | 454,729 88.84% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 11,324 | 21,382 | ||||||
BB yield | -0.06% | -0.10% | ||||||
| Debt | ||||||||
Debt current | 1,603,000 | 600,155 | 643,390 | |||||
Long-term debt | 20,244,000 | 18,330,163 | 13,099,976 | |||||
Deferred revenue | ||||||||
Other long-term liabilities | 293,000 | 289,889 | 278,798 | |||||
Net debt | 19,421,000 | 17,020,604 | 11,612,342 | |||||
| Cash flow | ||||||||
Cash from operating activities | 835,000 | 1,130,463 | 873,832 | |||||
CAPEX | (3,083,000) | (1,982,000) | (533,069) | |||||
Cash from investing activities | (2,791,000) | (1,011,935) | 48,270 | |||||
Cash from financing activities | 1,598,000 | 256,454 | (448,156) | |||||
FCF | (1,795,175) | (1,956,512) | (477,195) | |||||
| Balance | ||||||||
Cash | 1,526,000 | 1,884,006 | 1,509,024 | |||||
Long term investments | 900,000 | 25,708 | 622,000 | |||||
Excess cash | 1,820,250 | 1,416,121 | 1,736,308 | |||||
Stockholders' equity | 2,662,000 | 1,968,334 | 1,306,901 | |||||
Invested Capital | 15,103,750 | 12,458,895 | 8,900,196 | |||||
ROIC | 9.57% | 11.54% | 10.94% | |||||
ROCE | 9.97% | 11.38% | 11.74% | |||||
| EV | ||||||||
Common stock shares outstanding | 8,394 | 8,092 | 8,081 | |||||
Price | 1,390.00 -38.60% | 2,264.00 -12.38% | 2,584.00 11.91% | |||||
Market cap | 11,667,718 -36.31% | 18,320,585 -12.26% | 20,880,234 12.09% | |||||
EV | 31,088,718 | 35,341,189 | 32,518,773 | |||||
EBITDA | 2,218,000 | 1,990,608 | 1,534,606 | |||||
EV/EBITDA | 14.02 | 17.75 | 21.19 | |||||
Interest | 350,586 | 282,892 | ||||||
Interest/NOPBT | 22.20% | 23.62% | ||||||